Showing results (151-160 of 228) with videos related to

Sort By:
Pageof 23
Cancers|April 30, 2021
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 AlterationXian Chen, Dong Yang, Jason P W Carey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trialH S Han, B K Arun, B Kaufman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA MutationTapsi Kumar, Evie Hobbs, Fei Yang, et al.
Familial Cancer|September 28, 2013
Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromesThereasa A Rich, Mei Liu, Carol J Etzel, et al.
Vaccines|June 27, 2025
Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer CellsRicardo A León-Letelier, Alejandro M Sevillano-Mantas, Yihui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Annals of Surgical Oncology|December 11, 2012
Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancerKeila E Torres, Vinod Ravi, Katherine Kin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Cancer|March 27, 2018
Development of CNS metastases and survival in patients with inflammatory breast cancerMarc I Uemura, John T French, Kenneth R Hess, et al.
Breast Cancer Research and Treatment|March 7, 2012
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massHenry M Kuerer, Sara A Lari, Banu K Arun, et al.
Pageof 23